These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29661537)

  • 1. Pyridoxine dependent epilepsy: Is late onset a predictor for favorable outcome?
    de Rooy RLP; Halbertsma FJ; Struijs EA; van Spronsen FJ; Lunsing RJ; Schippers HM; van Hasselt PM; Plecko B; Wohlrab G; Whalen S; Benoist JF; Valence S; Mills PB; Bok LA
    Eur J Paediatr Neurol; 2018 Jul; 22(4):662-666. PubMed ID: 29661537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene.
    Plecko B; Paul K; Paschke E; Stoeckler-Ipsiroglu S; Struys E; Jakobs C; Hartmann H; Luecke T; di Capua M; Korenke C; Hikel C; Reutershahn E; Freilinger M; Baumeister F; Bosch F; Erwa W
    Hum Mutat; 2007 Jan; 28(1):19-26. PubMed ID: 17068770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal plasma pipecolic acid level in pyridoxine dependent epilepsy due to ALDH7A1 mutations.
    Mercimek-Mahmutoglu S; Donner EJ; Siriwardena K
    Mol Genet Metab; 2013; 110(1-2):197. PubMed ID: 23683770
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical, biochemical, and molecular studies in pyridoxine-dependent epilepsy. Antisense therapy as possible new therapeutic option.
    Pérez B; Gutiérrez-Solana LG; Verdú A; Merinero B; Yuste-Checa P; Ruiz-Sala P; Calvo R; Jalan A; Marín LL; Campos O; Ruiz MÁ; San Miguel M; Vázquez M; Castro M; Ferrer I; Navarrete R; Desviat LR; Lapunzina P; Ugarte M; Pérez-Cerdá C
    Epilepsia; 2013 Feb; 54(2):239-48. PubMed ID: 23350806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and genetic characteristics and detection of urinary pipecolic acid in pyridoxine dependent epilepsy].
    Xue J; Yang ZX; Li H; Qian P; Wu Y; Jiang YW; Liu XY
    Zhonghua Er Ke Za Zhi; 2016 Aug; 54(8):592-6. PubMed ID: 27510871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype, biochemical features, genotype and treatment outcome of pyridoxine-dependent epilepsy.
    Al Teneiji A; Bruun TU; Cordeiro D; Patel J; Inbar-Feigenberg M; Weiss S; Struys E; Mercimek-Mahmutoglu S
    Metab Brain Dis; 2017 Apr; 32(2):443-451. PubMed ID: 27882480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency).
    Mills PB; Footitt EJ; Mills KA; Tuschl K; Aylett S; Varadkar S; Hemingway C; Marlow N; Rennie J; Baxter P; Dulac O; Nabbout R; Craigen WJ; Schmitt B; Feillet F; Christensen E; De Lonlay P; Pike MG; Hughes MI; Struys EA; Jakobs C; Zuberi SM; Clayton PT
    Brain; 2010 Jul; 133(Pt 7):2148-59. PubMed ID: 20554659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel homozygous missense mutation in ALDH7A1 causes neonatal pyridoxine dependent epilepsy.
    Coci EG; Codutti L; Fink C; Bartsch S; Grüning G; Lücke T; Kurth I; Riedel J
    Mol Cell Probes; 2017 Apr; 32():18-23. PubMed ID: 27856333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy.
    Gallagher RC; Van Hove JL; Scharer G; Hyland K; Plecko B; Waters PJ; Mercimek-Mahmutoglu S; Stockler-Ipsiroglu S; Salomons GS; Rosenberg EH; Struys EA; Jakobs C
    Ann Neurol; 2009 May; 65(5):550-6. PubMed ID: 19142996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profound neonatal hypoglycemia and lactic acidosis caused by pyridoxine-dependent epilepsy.
    Mercimek-Mahmutoglu S; Horvath GA; Coulter-Mackie M; Nelson T; Waters PJ; Sargent M; Struys E; Jakobs C; Stockler-Ipsiroglu S; Connolly MB
    Pediatrics; 2012 May; 129(5):e1368-72. PubMed ID: 22529283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up.
    Stockler S; Plecko B; Gospe SM; Coulter-Mackie M; Connolly M; van Karnebeek C; Mercimek-Mahmutoglu S; Hartmann H; Scharer G; Struijs E; Tein I; Jakobs C; Clayton P; Van Hove JL
    Mol Genet Metab; 2011; 104(1-2):48-60. PubMed ID: 21704546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome in pyridoxine-dependent epilepsy.
    Bok LA; Halbertsma FJ; Houterman S; Wevers RA; Vreeswijk C; Jakobs C; Struys E; Van Der Hoeven JH; Sival DA; Willemsen MA
    Dev Med Child Neurol; 2012 Sep; 54(9):849-54. PubMed ID: 22804844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridoxine-dependent epilepsy due to antiquitin deficiency: achieving a favourable outcome.
    Oliveira R; Pereira C; Rodrigues F; Alfaite C; Garcia P; Robalo C; Fineza I; Gonçalves O; Struys E; Salomons G; Jakobs C; Diogo L
    Epileptic Disord; 2013 Dec; 15(4):400-6. PubMed ID: 24184718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridoxine-dependent epilepsy in Tunisia is caused by a founder missense mutation of the ALDH7A1 gene.
    Tlili A; Hamida Hentati N; Chaabane R; Gargouri A; Fakhfakh F
    Gene; 2013 Apr; 518(2):242-5. PubMed ID: 23376216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EEG response to pyridoxine-IV neither identifies nor excludes pyridoxine-dependent epilepsy.
    Bok LA; Maurits NM; Willemsen MA; Jakobs C; Teune LK; Poll-The BT; de Coo IF; Toet MC; Hagebeuk EE; Brouwer OF; van der Hoeven JH; Sival DA
    Epilepsia; 2010 Dec; 51(12):2406-11. PubMed ID: 20887371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cohort study of pyridoxine-dependent epilepsy and high prevalence of splice site IVS11+1G>A mutation in Chinese patients.
    Xue J; Qian P; Li H; Wu Y; Liu X; Yang Z
    Epilepsy Res; 2015 Dec; 118():1-4. PubMed ID: 26555630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seizure recurrence following pyridoxine withdrawal in a patient with pyridoxine-dependent epilepsy.
    Tamaura M; Shimbo H; Iai M; Yamashita S; Osaka H
    Brain Dev; 2015 Apr; 37(4):442-5. PubMed ID: 25123644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapy for pyridoxine dependent epilepsy due to ALDH7A1 genetic defect: L-arginine supplementation alternative to lysine-restricted diet.
    Mercimek-Mahmutoglu S; Cordeiro D; Cruz V; Hyland K; Struys EA; Kyriakopoulou L; Mamak E
    Eur J Paediatr Neurol; 2014 Nov; 18(6):741-6. PubMed ID: 25127453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prospective Case Study of the Safety and Efficacy of Lysine-Restricted Diet and Arginine Supplementation Therapy in a Patient With Pyridoxine-Dependent Epilepsy Caused by Mutations in ALDH7A1.
    Mahajnah M; Corderio D; Austin V; Herd S; Mutch C; Carter M; Struys E; Mercimek-Mahmutoglu S
    Pediatr Neurol; 2016 Jul; 60():60-5. PubMed ID: 27212567
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.